Geron Corp. (GERN)
1.195
+0.02
(+2.14%)
USD |
NASDAQ |
Oct 19, 16:00
1.21
+0.02
(+1.26%)
After-Hours: 17:21
Geron Cash from Operations (Annual) : -111.04M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -111.04M |
| December 31, 2024 | -218.62M |
| December 31, 2023 | -167.74M |
| December 31, 2022 | -127.38M |
| December 31, 2021 | -95.56M |
| December 31, 2020 | -66.65M |
| December 31, 2019 | -43.83M |
| December 31, 2018 | -21.01M |
| December 31, 2017 | -20.56M |
| December 31, 2016 | -18.37M |
| December 31, 2015 | -24.20M |
| December 31, 2014 | 9.35M |
| December 31, 2013 | -36.68M |
| December 31, 2012 | -55.15M |
| December 31, 2011 | -62.39M |
| Date | Value |
|---|---|
| December 31, 2010 | -44.29M |
| December 31, 2009 | -43.37M |
| December 31, 2008 | -41.98M |
| December 31, 2007 | -26.63M |
| December 31, 2006 | -26.38M |
| December 31, 2005 | -20.61M |
| December 31, 2004 | -25.92M |
| December 31, 2003 | -24.40M |
| December 31, 2002 | -31.34M |
| December 31, 2001 | -22.42M |
| December 31, 2000 | -13.60M |
| December 31, 1999 | -13.60M |
| December 31, 1998 | -7.789M |
| December 31, 1997 | -7.856M |
| December 31, 1996 | -9.949M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Precigen, Inc. | -87.83M |
| Editas Medicine, Inc. | -165.24M |
| Agenus, Inc. | -77.20M |
| Amgen, Inc. | 9.958B |
| Anika Therapeutics, Inc. | 11.19M |